Menu
GeneBe

rs4986939

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004629.2(FANCG):c.1133C>T(p.Ser378Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00551 in 1,614,082 control chromosomes in the GnomAD database, including 437 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S378S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.030 ( 248 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 189 hom. )

Consequence

FANCG
NM_004629.2 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: -0.202
Variant links:
Genes affected
FANCG (HGNC:3588): (FA complementation group G) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015013218).
BP6
Variant 9-35075972-G-A is Benign according to our data. Variant chr9-35075972-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 134370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-35075972-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FANCGNM_004629.2 linkuse as main transcriptc.1133C>T p.Ser378Leu missense_variant 9/14 ENST00000378643.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FANCGENST00000378643.8 linkuse as main transcriptc.1133C>T p.Ser378Leu missense_variant 9/141 NM_004629.2 P2

Frequencies

GnomAD3 genomes
AF:
0.0300
AC:
4570
AN:
152160
Hom.:
247
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0127
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.0187
GnomAD3 exomes
AF:
0.00791
AC:
1987
AN:
251262
Hom.:
95
AF XY:
0.00621
AC XY:
844
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.00521
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00296
AC:
4326
AN:
1461804
Hom.:
189
Cov.:
32
AF XY:
0.00254
AC XY:
1847
AN XY:
727198
show subpopulations
Gnomad4 AFR exome
AF:
0.105
Gnomad4 AMR exome
AF:
0.00601
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000162
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000132
Gnomad4 OTH exome
AF:
0.00628
GnomAD4 genome
AF:
0.0300
AC:
4574
AN:
152278
Hom.:
248
Cov.:
32
AF XY:
0.0293
AC XY:
2181
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.104
Gnomad4 AMR
AF:
0.0127
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000294
Gnomad4 OTH
AF:
0.0185
Alfa
AF:
0.00649
Hom.:
108
Bravo
AF:
0.0347
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.101
AC:
444
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00964
AC:
1170
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group G Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
not specified Benign:2Other:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
not provided, no classification providedreference populationITMISep 19, 2013- -
Fanconi anemia Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMay 25, 2019- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Amyotrophic Lateral Sclerosis, Dominant Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Inclusion Body Myopathy, Dominant Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.79
Cadd
Benign
6.7
Dann
Uncertain
0.98
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0015
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.082
Sift
Benign
0.46
T
Sift4G
Uncertain
0.020
D
Polyphen
0.027
B
Vest4
0.064
MVP
0.20
MPC
0.19
ClinPred
0.0055
T
GERP RS
2.4
Varity_R
0.028
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4986939; hg19: chr9-35075969; COSMIC: COSV62721600; COSMIC: COSV62721600; API